| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.14 | 0.7 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |